Role of non-neuronal nicotinic acetylcholine receptors in angiogenesis
Angiogenesis is a critical physiological process for cell survival and development. Endothelial cells, necessary for the course of angiogenesis, express several non-neuronal nicotinic acetylcholine receptors (AChRs). The most important functional non-neuronal AChRs are homomeric alpha7 AChRs and sev...
Gespeichert in:
Veröffentlicht in: | The international journal of biochemistry & cell biology 2009-07, Vol.41 (7), p.1441-1451 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1451 |
---|---|
container_issue | 7 |
container_start_page | 1441 |
container_title | The international journal of biochemistry & cell biology |
container_volume | 41 |
creator | Arias, Hugo R Richards, Victoria E Ng, David Ghafoori, Mary E Le, Vanique Mousa, Shaker A |
description | Angiogenesis is a critical physiological process for cell survival and development. Endothelial cells, necessary for the course of angiogenesis, express several non-neuronal nicotinic acetylcholine receptors (AChRs). The most important functional non-neuronal AChRs are homomeric alpha7 AChRs and several heteromeric AChRs formed by a combination of alpha3, alpha5, beta2, and beta4 subunits, including alpha3beta4-containing AChRs. In endothelial cells, alpha7 AChR stimulation indirectly triggers the activation of the integrin alphavbeta3 receptor and an intracellular MAP kinase (ERK) pathway that mediates angiogenesis. Non-selective cholinergic agonists such as nicotine have been shown to induce angiogenesis, enhancing tumor progression. Moreover, alpha7 AChR selective antagonists such as alpha-bungarotoxin and methyllycaconitine as well as the non-specific antagonist mecamylamine have been shown to inhibit endothelial cell proliferation and ultimately blood vessel formation. Exploitation of such pharmacologic properties can lead to the discovery of new specific cholinergic antagonists as anti-cancer therapies. Conversely, the pro-angiogenic effect elicited by specific agonists can be used to treat diseases that respond to revascularization such as diabetic ischemia and atherosclerosis, as well as to accelerate wound healing. In this mini-review we discuss the pharmacological evidence supporting the importance of non-neuronal AChRs in angiogenesis. We also explore potential intracellular mechanisms by which alpha7 AChR activation mediates this vital cellular process. |
doi_str_mv | 10.1016/j.biocel.2009.01.013 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67175964</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67175964</sourcerecordid><originalsourceid>FETCH-LOGICAL-c402t-7d47ae846fbf1a54f343788b33c32c29b9aed9bcc480593bc4a3d5aa8de824be3</originalsourceid><addsrcrecordid>eNqFkEFLAzEUhIMoVqv_QGRP3nZNNskme5RiVSgIoueQZN_WlG1Sk91D_70pLXgUhvfmMDOHD6E7giuCSfO4qYwLFoaqxritMMmiZ-iKSCFLLgU_z55yUdai5jN0ndIGY0x4TS_RjLQME8LYFVp-hAGK0Bc--NLDFIPXQ-GdDaPLt9AWxv1gv8PgPBQRLOzGEFPhfKH92oU1eEgu3aCLXg8Jbk9_jr6Wz5-L13L1_vK2eFqVluF6LEXHhAbJmt70RHPWU0aFlIZSS2tbt6bV0LXGWiYxb6mxTNOOay07kDUzQOfo4bi7i-FngjSqrUsZwqA9hCmpRhDB24b9G8zQBM5kcpAdgzaGlCL0ahfdVse9IlgdQKuNOoI-dFqFSRbNtfvT_mS20P2VTmTpL6FkfGc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20070725</pqid></control><display><type>article</type><title>Role of non-neuronal nicotinic acetylcholine receptors in angiogenesis</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Arias, Hugo R ; Richards, Victoria E ; Ng, David ; Ghafoori, Mary E ; Le, Vanique ; Mousa, Shaker A</creator><creatorcontrib>Arias, Hugo R ; Richards, Victoria E ; Ng, David ; Ghafoori, Mary E ; Le, Vanique ; Mousa, Shaker A</creatorcontrib><description>Angiogenesis is a critical physiological process for cell survival and development. Endothelial cells, necessary for the course of angiogenesis, express several non-neuronal nicotinic acetylcholine receptors (AChRs). The most important functional non-neuronal AChRs are homomeric alpha7 AChRs and several heteromeric AChRs formed by a combination of alpha3, alpha5, beta2, and beta4 subunits, including alpha3beta4-containing AChRs. In endothelial cells, alpha7 AChR stimulation indirectly triggers the activation of the integrin alphavbeta3 receptor and an intracellular MAP kinase (ERK) pathway that mediates angiogenesis. Non-selective cholinergic agonists such as nicotine have been shown to induce angiogenesis, enhancing tumor progression. Moreover, alpha7 AChR selective antagonists such as alpha-bungarotoxin and methyllycaconitine as well as the non-specific antagonist mecamylamine have been shown to inhibit endothelial cell proliferation and ultimately blood vessel formation. Exploitation of such pharmacologic properties can lead to the discovery of new specific cholinergic antagonists as anti-cancer therapies. Conversely, the pro-angiogenic effect elicited by specific agonists can be used to treat diseases that respond to revascularization such as diabetic ischemia and atherosclerosis, as well as to accelerate wound healing. In this mini-review we discuss the pharmacological evidence supporting the importance of non-neuronal AChRs in angiogenesis. We also explore potential intracellular mechanisms by which alpha7 AChR activation mediates this vital cellular process.</description><identifier>ISSN: 1357-2725</identifier><identifier>EISSN: 1878-5875</identifier><identifier>DOI: 10.1016/j.biocel.2009.01.013</identifier><identifier>PMID: 19401144</identifier><language>eng</language><publisher>Netherlands</publisher><subject>Animals ; Humans ; Inflammation - metabolism ; Inflammation - pathology ; Neoplasms - blood supply ; Neovascularization, Pathologic - metabolism ; Neovascularization, Physiologic ; Neurons - metabolism ; Receptors, Nicotinic - metabolism</subject><ispartof>The international journal of biochemistry & cell biology, 2009-07, Vol.41 (7), p.1441-1451</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c402t-7d47ae846fbf1a54f343788b33c32c29b9aed9bcc480593bc4a3d5aa8de824be3</citedby><cites>FETCH-LOGICAL-c402t-7d47ae846fbf1a54f343788b33c32c29b9aed9bcc480593bc4a3d5aa8de824be3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19401144$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arias, Hugo R</creatorcontrib><creatorcontrib>Richards, Victoria E</creatorcontrib><creatorcontrib>Ng, David</creatorcontrib><creatorcontrib>Ghafoori, Mary E</creatorcontrib><creatorcontrib>Le, Vanique</creatorcontrib><creatorcontrib>Mousa, Shaker A</creatorcontrib><title>Role of non-neuronal nicotinic acetylcholine receptors in angiogenesis</title><title>The international journal of biochemistry & cell biology</title><addtitle>Int J Biochem Cell Biol</addtitle><description>Angiogenesis is a critical physiological process for cell survival and development. Endothelial cells, necessary for the course of angiogenesis, express several non-neuronal nicotinic acetylcholine receptors (AChRs). The most important functional non-neuronal AChRs are homomeric alpha7 AChRs and several heteromeric AChRs formed by a combination of alpha3, alpha5, beta2, and beta4 subunits, including alpha3beta4-containing AChRs. In endothelial cells, alpha7 AChR stimulation indirectly triggers the activation of the integrin alphavbeta3 receptor and an intracellular MAP kinase (ERK) pathway that mediates angiogenesis. Non-selective cholinergic agonists such as nicotine have been shown to induce angiogenesis, enhancing tumor progression. Moreover, alpha7 AChR selective antagonists such as alpha-bungarotoxin and methyllycaconitine as well as the non-specific antagonist mecamylamine have been shown to inhibit endothelial cell proliferation and ultimately blood vessel formation. Exploitation of such pharmacologic properties can lead to the discovery of new specific cholinergic antagonists as anti-cancer therapies. Conversely, the pro-angiogenic effect elicited by specific agonists can be used to treat diseases that respond to revascularization such as diabetic ischemia and atherosclerosis, as well as to accelerate wound healing. In this mini-review we discuss the pharmacological evidence supporting the importance of non-neuronal AChRs in angiogenesis. We also explore potential intracellular mechanisms by which alpha7 AChR activation mediates this vital cellular process.</description><subject>Animals</subject><subject>Humans</subject><subject>Inflammation - metabolism</subject><subject>Inflammation - pathology</subject><subject>Neoplasms - blood supply</subject><subject>Neovascularization, Pathologic - metabolism</subject><subject>Neovascularization, Physiologic</subject><subject>Neurons - metabolism</subject><subject>Receptors, Nicotinic - metabolism</subject><issn>1357-2725</issn><issn>1878-5875</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEFLAzEUhIMoVqv_QGRP3nZNNskme5RiVSgIoueQZN_WlG1Sk91D_70pLXgUhvfmMDOHD6E7giuCSfO4qYwLFoaqxritMMmiZ-iKSCFLLgU_z55yUdai5jN0ndIGY0x4TS_RjLQME8LYFVp-hAGK0Bc--NLDFIPXQ-GdDaPLt9AWxv1gv8PgPBQRLOzGEFPhfKH92oU1eEgu3aCLXg8Jbk9_jr6Wz5-L13L1_vK2eFqVluF6LEXHhAbJmt70RHPWU0aFlIZSS2tbt6bV0LXGWiYxb6mxTNOOay07kDUzQOfo4bi7i-FngjSqrUsZwqA9hCmpRhDB24b9G8zQBM5kcpAdgzaGlCL0ahfdVse9IlgdQKuNOoI-dFqFSRbNtfvT_mS20P2VTmTpL6FkfGc</recordid><startdate>200907</startdate><enddate>200907</enddate><creator>Arias, Hugo R</creator><creator>Richards, Victoria E</creator><creator>Ng, David</creator><creator>Ghafoori, Mary E</creator><creator>Le, Vanique</creator><creator>Mousa, Shaker A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>200907</creationdate><title>Role of non-neuronal nicotinic acetylcholine receptors in angiogenesis</title><author>Arias, Hugo R ; Richards, Victoria E ; Ng, David ; Ghafoori, Mary E ; Le, Vanique ; Mousa, Shaker A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c402t-7d47ae846fbf1a54f343788b33c32c29b9aed9bcc480593bc4a3d5aa8de824be3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Humans</topic><topic>Inflammation - metabolism</topic><topic>Inflammation - pathology</topic><topic>Neoplasms - blood supply</topic><topic>Neovascularization, Pathologic - metabolism</topic><topic>Neovascularization, Physiologic</topic><topic>Neurons - metabolism</topic><topic>Receptors, Nicotinic - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arias, Hugo R</creatorcontrib><creatorcontrib>Richards, Victoria E</creatorcontrib><creatorcontrib>Ng, David</creatorcontrib><creatorcontrib>Ghafoori, Mary E</creatorcontrib><creatorcontrib>Le, Vanique</creatorcontrib><creatorcontrib>Mousa, Shaker A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The international journal of biochemistry & cell biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arias, Hugo R</au><au>Richards, Victoria E</au><au>Ng, David</au><au>Ghafoori, Mary E</au><au>Le, Vanique</au><au>Mousa, Shaker A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of non-neuronal nicotinic acetylcholine receptors in angiogenesis</atitle><jtitle>The international journal of biochemistry & cell biology</jtitle><addtitle>Int J Biochem Cell Biol</addtitle><date>2009-07</date><risdate>2009</risdate><volume>41</volume><issue>7</issue><spage>1441</spage><epage>1451</epage><pages>1441-1451</pages><issn>1357-2725</issn><eissn>1878-5875</eissn><abstract>Angiogenesis is a critical physiological process for cell survival and development. Endothelial cells, necessary for the course of angiogenesis, express several non-neuronal nicotinic acetylcholine receptors (AChRs). The most important functional non-neuronal AChRs are homomeric alpha7 AChRs and several heteromeric AChRs formed by a combination of alpha3, alpha5, beta2, and beta4 subunits, including alpha3beta4-containing AChRs. In endothelial cells, alpha7 AChR stimulation indirectly triggers the activation of the integrin alphavbeta3 receptor and an intracellular MAP kinase (ERK) pathway that mediates angiogenesis. Non-selective cholinergic agonists such as nicotine have been shown to induce angiogenesis, enhancing tumor progression. Moreover, alpha7 AChR selective antagonists such as alpha-bungarotoxin and methyllycaconitine as well as the non-specific antagonist mecamylamine have been shown to inhibit endothelial cell proliferation and ultimately blood vessel formation. Exploitation of such pharmacologic properties can lead to the discovery of new specific cholinergic antagonists as anti-cancer therapies. Conversely, the pro-angiogenic effect elicited by specific agonists can be used to treat diseases that respond to revascularization such as diabetic ischemia and atherosclerosis, as well as to accelerate wound healing. In this mini-review we discuss the pharmacological evidence supporting the importance of non-neuronal AChRs in angiogenesis. We also explore potential intracellular mechanisms by which alpha7 AChR activation mediates this vital cellular process.</abstract><cop>Netherlands</cop><pmid>19401144</pmid><doi>10.1016/j.biocel.2009.01.013</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1357-2725 |
ispartof | The international journal of biochemistry & cell biology, 2009-07, Vol.41 (7), p.1441-1451 |
issn | 1357-2725 1878-5875 |
language | eng |
recordid | cdi_proquest_miscellaneous_67175964 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Animals Humans Inflammation - metabolism Inflammation - pathology Neoplasms - blood supply Neovascularization, Pathologic - metabolism Neovascularization, Physiologic Neurons - metabolism Receptors, Nicotinic - metabolism |
title | Role of non-neuronal nicotinic acetylcholine receptors in angiogenesis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T19%3A40%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20non-neuronal%20nicotinic%20acetylcholine%20receptors%20in%20angiogenesis&rft.jtitle=The%20international%20journal%20of%20biochemistry%20&%20cell%20biology&rft.au=Arias,%20Hugo%20R&rft.date=2009-07&rft.volume=41&rft.issue=7&rft.spage=1441&rft.epage=1451&rft.pages=1441-1451&rft.issn=1357-2725&rft.eissn=1878-5875&rft_id=info:doi/10.1016/j.biocel.2009.01.013&rft_dat=%3Cproquest_cross%3E67175964%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20070725&rft_id=info:pmid/19401144&rfr_iscdi=true |